Shuttle Pharmaceuticals Holdings, Inc. (SHPH) ownership: Top institutional holder: Ikarian Capital, LLC ($46832.00). Insider activity: Net Seller (6 buys, 14 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Ikarian Capital, LLC | 68993.00 | $46832.00 | 2026-03-31 |
| CITADEL ADVISORS LLC | 94916.00 | $36922.00 | 2025-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 46217.00 | $31371.00 | 2026-03-31 |
| BOOTHBAY FUND MANAGEMENT, LLC | 20360.00 | $13820.00 | 2026-03-31 |
| Virtu Financial LLC | 12380.00 | $8000.00 | 2026-03-31 |
| UBS Group AG | 5670.00 | $3850.00 | 2026-03-31 |
| RAYMOND JAMES FINANCIAL INC | 1000.00 | $3765.00 | 2025-06-30 |
| Tower Research Capital LLC (TRC) | 4641.00 | $3150.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-07-09 | |
| Sell | null | 2026-07-09 | |
| Buy | null | 2026-07-09 | |
| Buy | null | 2026-07-09 | |
| Sell | null | 2026-06-29 | |
| Sell | null | 2026-06-29 | |
| Sell | null | 2026-06-29 | |
| Buy | null | 2026-06-29 |
Back to SHPH overview · SHPH earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.